Bachelor's degree, Finance & Organizational Behavior @
La Salle University
A Strategic and Operational CFO with broad & deep geographic and business experience in Pharmaceutical, Biotech, Medical Device & Consumer Goods leading international markets worldwide in Financial operations, General Management, Information Technology, Procurement & Facilities. A strategic thinker partnering with leadership to develop long-range plans and deliver business & financial results through fact-based decision support, developing diverse
A Strategic and Operational CFO with broad & deep geographic and business experience in Pharmaceutical, Biotech, Medical Device & Consumer Goods leading international markets worldwide in Financial operations, General Management, Information Technology, Procurement & Facilities. A strategic thinker partnering with leadership to develop long-range plans and deliver business & financial results through fact-based decision support, developing diverse cross-functional talent and implementing comprehensive metrics. Identify and sponsor change through P&L efficiencies, improved cash flow and new business models, fueling profit growth and margin expansion. Appling this approach to lead “beyond the numbers” with broad business acumen to impact the business.
Recognized as a thought leader and business partner with a hands-on approach going beyond the financial leader role, a strong communicator who sorts through complexity and asks the right questions, willing to challenge the status quo & lead transformational change. Develop global finance organizations, placing leaders beyond the finance function.
Experienced Management Board member of various sized healthcare, life science and consumer goods companies from start-up to multi-billion dollar global market leaders, driving high-growth businesses, improving turn-arounds and acquisition integration. Led financial organizations from 5 to 200 employees.
Areas of expertise:
Growth Strategies | Global Leadership | Board Member | Fact-Based Decision Support | Strategic & Financial Planning | Worldwide P&L Management | International Finance | Cost Accounting | Competitive Intelligence | Talent Development
Internal Financial Controls | Financial & Portfolio Analysis | Tax Planning | International Treasury Functions | Capital Structure & Cash Management | Mergers & Acquisition | Project Management | Investor Relations | New Product Launches | Acquisition Integration
Senior Vice President and Chief Financial Officer @ Globus Medical, Inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. Founded in 2003, Globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. Globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. From April 2015 to Present (5 months) Greater Philadelphia AreaChief Financial Officer, Worldwide Vice President Finance and Business Operations @ CFO and Board member for +$3 billion global Vision Care business with worldwide P&L accountability, partnering with leadership to develop and execute strategic and operational growth plans. Lead a finance team of +200 employees in 54 countries.
Implemented new strategic price reset; improved P&L effectiveness and margin expansion; eliminated critical backorders, raising order fill; accelerated new product development; developed global competitive analytics; strengthened global commercial capabilities and competitiveness. From March 2012 to February 2015 (3 years) Jacksonville, Florida AreaChief Financial Officer, Worldwide Vice President Finance @ CFO and Board member for +$1 billion global sterilization & disinfection unit of Johnson & Johnson with worldwide P&L accountability, partnered with Board and key partners to lead business turn-around into sustained market-leading growth, while improving P&L efficiencies and long term growth strategies. Led team 35 finance employees worldwide.
Generated significant sales growth; accelerated cash flow and improved profitability; drove margin expansion; partnered directly with hospitals and key accounts; created and led manufacturing expansion in US and tax-advantaged locations; built strong worldwide finance team focused on business partnering, solutions, engagement, profitability improvement & compliance. From September 2007 to March 2012 (4 years 7 months) Irvine, CaliforniaFinance Director: Marketing, Sales, Resarch & Development @ Finance Director for US Marketing, Sales and R&D organizations supporting +$2 billion Over The Counter (OTC) portfolio including Tylenol, Motrin, Zyrtec, Pepcid and Imodium. Led Marketing Finance acquisition integration of Pfizer OTC products including realization of over $150 million of synergies; supported successful Zyrtec OTC launch from prescription market; developed financial tools to drive focus and profitability of combined portfolio. Led finance team of 30 employees. From October 2006 to September 2007 (1 year) Greater Philadelphia AreaFinance Director: Research & Development | Board Member @ Finance Director and R&D Board member partnering with R&D leadership.
Responsible for biologics (large molecule) early & late-stage development portfolio investments. Identified cost saving and project management efficiencies, freeing cash flow to be redeployed into expanded indications & treatment for oncology patients; shaped culture of organization by partnering with new President; improved long-term cash flow through tax planning; established and funded new stem cell program. Recruited and developed a team of 35 finance employees, installed SAP ERP system for stronger compliance, analytics and tax records. From May 2003 to October 2006 (3 years 6 months) Greater Philadelphia AreaDirector of Finance, IT and Administration @ Finance Director and Board member for large Pharmaceutical manufacturing facility supplying Biologics, Pharmaceuticals and Chemical APIs to European and Asian markets. Designed, negotiated and implemented custom tax ruling with Swiss Federal and regional governments creating zero tax zone for new economic development resulting in 400% growth making Cilag one of J&J’s strategic production facilities. From August 1999 to May 2003 (3 years 10 months) Schaffhausen, SwitzerlandEuropean Director of Finance & Administration @ From January 1998 to January 1999 (1 year 1 month) Bassersdorf SwitzerlandPlant Controller @ From January 1996 to January 1998 (2 years 1 month) Ft Washington, PaManager Worldwide Financial Planning & Analysis (FP&A) @ From January 1993 to January 1996 (3 years 1 month) Whitehouse Station, NJSr Financial Brand Analyst @ From January 1991 to January 1993 (2 years 1 month) Ft Washington, PASr Marketing & Sales Analyst/ Cost Accountant @ From May 1986 to January 1991 (4 years 9 months) Springhouse, Pa
Master of Business Administration (MBA), International Business, Cum Laude @ Temple University From 1990 to 1993 Bachelor's degree, Finance & Organizational Behavior, Magna Cum Laude @ La Salle University From 1983 to 1987 Daniel Scavilla is skilled in: Growth Strategies, Global Leadership, Fact-based Analysis, Trend Analysis, Strategic Planning, P&L Management, Competitive Intelligence, Talent Developer, Internal Controls, Process Improvement, Forecasting, Mergers & Acquisitions, Corporate FP&A, Cross-functional Team..., Sarbanes-Oxley Act, Financial Modeling, Financial Analysis, Managerial Finance, Leadership, Business Development, Strategy, Business Planning, Corporate Finance, Finance, Management, Biotechnology, Pharmaceutical Industry, Medical Devices, Financial Planning, Strategic Financial..., Consumer Products, Stem Cell Research
Looking for a different
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension